Sunrise aims to democratize access to care for sleep apnea syndrome. This serious respiratory disorder is known for multiplying mortality risk by factor 3. The Sunrise innovation is based on more than ten years of research : the technology detects respiratory events based on the analysis of the respiratory drive (which is reflected in the contractions of the respiratory muscles and the movements these cause at the level of the chin). In 2021, it gained an award at the CES in Las Vegas. Currently, about twenty people (located in Belgium and France) work for Sunrise, a scale-up that aims to market its medical device in the United States and France.